Walleye Capital’s 1Life Healthcare ONEM Stock Holding History

Walleye Capital’s Portfolio ONEM Stock Details ONEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-73,403	Closed	-$1.23M	–	4633
2022 Q4	$1.23M	Buy	73,403 +18,988	+35%	+$321K	0.02%	871
2022 Q3	$933K	Buy	+54,415	New	+$854K	0.02%	1031
2022 Q2	–	Sell	-51,134	Closed	-$567K	–	2829
2022 Q1	$567K	Buy	+51,134	New	+$573K	0.02%	944
2021 Q3	–	Sell	-9,790	Closed	-$324	–	1914
2021 Q2	$324	Buy	+9,790	New	+$370K	0.01%	902
2021 Q1	–	Sell	-8,384	Closed	-$366	–	1424
2020 Q4	$366	Buy	+8,384	New	+$286K	0.02%	573

Walleye Capital's ONEM Position: Q1 2023 in Review

Walleye Capital sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 73,403 shares — an estimated $1.23M sold.

Walleye Capital first reported a position in ONEM in Q4 2020 and held it in 5 quarters. The position peaked at $1.23M in Q4 2022. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

Walleye Capital reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
Walleye Capital sold 73,403 1Life Healthcare shares in Q1 2023, an estimated $1.23M.
Walleye Capital first reported a position in 1Life Healthcare in Q4 2020 and held it in 5 quarters.
Walleye Capital's 1Life Healthcare position peaked at $1.23M in Q4 2022.
0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Walleye Capital's 13F filing for Q1 2023, filed 15 May 2023.